Safety of Off‐Label Use of Ferumoxtyol as a Contrast Agent for MRI: A Systematic Review and Meta‐Analysis of Adverse Events

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1PRISMA harms checklist: improving harms reporting in systematic reviews2016 · 561 citations
2. 2High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material2013 · 1,350 citations
3. 3Physicochemical properties of ferumoxytol, a new intravenous iron preparation2009 · 143 citations
4. 4Ferumoxytol in clinical practice: Implications for MRI2012 · 70 citations
5. 5Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy2015 · 880 citations